Stadol
Addiction, Detox and Treatment
Posed to be a less harmful prescription drug, Stadol
NS (butorphanol), a nasal spray, form of painkiller,
in reality, has been exposed to be the cause for several
deaths. The FDA has logged a significant amount of deaths
and severe addictions report associated with Stadol. The
spray has been linked to hundreds of cases of addiction
and numerous deaths.
Expressed as Tartrate salt, the nasal spray contains a
composition of Butorphanol tartrate, a crystalline substance.
One milligram of the salt is equivalent to 0.68 mg of the
free base. The n-octanol/aqueous buffer partition coefficient
of butorphanol is 180:1 at pH 7.5.
The Stadol Injection, USP, is
a sterile, parenteral, aqueous solution of butorphanol tartrate
for intravenous or intramuscularly administration. In addition
to 1 or 2 mg of butorphanol tartrate, each mL of solution
contains 3.3 mg of citric acid, 6.4 mg sodium citrate, and
6.4 mg sodium chloride, and 0.1 mg benzethonium chloride
(in multiple dose vial only) and a preservative.
STADOL NS is an aqueous solution
of butorphanol tartate for administration as a metered spray
to the nasal mucosa. Each bottle of STADOL NS contains 2.5
ml of a 10 mg/ml solution of butorphanol tartate with sodium
chloride, citric acid, and benzethonium chloride in purified
water with sodium hydroxide and/or hydrochloric acid added
to adjust the pH to 5.0.
The nasal spray is a pain reliever for moderate or severe
pain. The patient is put under butorphanol dose every 3-4
hours either as a nasal sprays or injected into the buttock
or hip muscle or into a vein. Typically prescribed for patients
recovering from surgery, or migraine headaches the nasal
spray works by binding to the pain receptors in the brain.
Factors to be considered before taking the dose are age,
body weight, physical status, and underlying pathological
condition, use of other drugs, type of anesthesia to be
used, and surgical procedure involved. Use in the elderly,
patients with hepatic or renal disease or in labor requires
extra caution.
Associated with occurrence of abuse and dependence with
most reports involving outpatient treatment of chronic painful
conditions, Butorphanol tartrate can be life threatening.
People may experience asthenia/lethargy, headache, sensation
of heat, dry mouth, nausea and/or vomiting stomach pain,
anxiety, dizziness, insomnia, nervousness, cough, nasal
congestion and/or irritation, sweating, blurred vision,
ear pain, and tinnitus (ringing in ears).
Detox
Program
Rapid Detoxification is a short-term
treatment of Stadol addiction where it minimize or eliminates
the signs and symptoms related with opiate withdrawal, thereby
decreasing the chances of relapse to opiate dependence.
However, it is not meant to replace a comprehensive treatment
program, but rather act as a stepping-stone to help an individual
tolerate the withdrawal symptoms from opiates with much
greater comfort. Once 'clean' of all opiates, abusers are
strongly advised to begin the work of addiction recovery
by getting involved in some form of counseling.
Behavioral
Therapy
Behavioral therapies can include counseling, psychotherapy,
support groups, or family therapy. For a long-term success,
medical therapy alone hardly ever helps, thus effective
treatment of such drug addiction requires plenty of attention.
Medical treatment should be combined with concurrent behavioral
therapies and provision for social services.
Methadone
Treatment
These treatment programs use Methadone, a long acting opiod,
which helps to stabilize the lives of people who are dependent
on opiates and reduce the harm related to drug use.
Methadone is a narcotic, medication lasting for around 24-36
hours per dose. It is an effective and legal substitute
for heroin or other narcotics (e.g., morphine, percocet,
percodan, dilaudid, codeine, etc.) It works best when combined
with other services and involvements as it helps patients
return to stable social, economic, and home environment.
Patients are provided with individual and group counseling
to promote relapse prevention, further, the treatment program
addresses multiple medical issues.
DEA’s
Approach
Currently DEA’s approach has been introduced to combat
the diversion of pharmaceutical controlled substances. These
approaches include; liaison with the healthcare community,
the pharmaceutical industry, and other domestic and international
agencies; education of medical professionals regarding various
scams that are used to obtain controlled substances for
illicit purposes; and the investigation of suspected diverters.
For
More Information on Stadol Addiction
and A Free Professional Consultation Call
800-559-9503
Anytime Day or Night.
|
|
